Will Bayer Supplement-Drug Combo Draw Other Firms Into New Market?
This article was originally published in The Tan Sheet
Executive Summary
FDA's silence about Bayer's launch of Aspirin with Heart Advantage could speak volumes about a possible new marketing opportunity
You may also be interested in...
Bayer Reboots Heart Advantage With Promotion For Aspirin
Bayer is using the reformulation of its Bayer Heart Health Advantage cholesterol-lowering phytosterol supplement as an opportunity to cross-promote with its aspirin brand
Bayer Reboots Heart Advantage With Promotion For Aspirin
Bayer is using the reformulation of its Bayer Heart Health Advantage cholesterol-lowering phytosterol supplement as an opportunity to cross-promote with its aspirin brand
Bayer Reboots Heart Advantage With Promotion For Aspirin
Bayer is using the reformulation of its Bayer Heart Health Advantage cholesterol-lowering phytosterol supplement as an opportunity to cross-promote with its aspirin brand